Investor · 1 deal
Every published round Nakatomi Venture Studio took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Ovum | Pre-seed | 4 Feb 2025 | $1.7m | Participant | Startup Daily (23 Jun 2026), Women's Agenda (23 Jun 2026), Forbes Australia (23 Jun 2026), Dealroom, Startup Daily (16 Jun 2026), Startup Daily (22 Jul 2025), Women's Agenda (5 Jun 2025), Women's Agenda (4 Apr 2025), Startup Daily (4 Feb 2025), Forbes Australia (4 Feb 2025) |
Companies Nakatomi Venture Studio has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ovum | AI-powered women's health platform building a longitudinal health dataset. | 4 Feb 2025, Pre-seed | 1 | 0 |
Fund closes reported for Nakatomi Venture Studio, as distinct from the investments it has made.
Companies Nakatomi Venture Studio has backed that another company then bought. An exit for the holding, not a deal Nakatomi Venture Studio did.
Stories naming Nakatomi Venture Studio. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Ovum, an app for tracking menstrual and women's health, has secured $1.7m to launch its AI assistant, in a round led by Giant Leap with Antler, Wollemi Capital and other backers.
Also Forbes Australia·Startup Daily·Startup Daily·Startup Daily·Women's Agenda·Women's Agenda·Dealroom·Forbes Australia·Women's Agenda